Study of inhaler device attributes investigating critical and overall errors, ease of use, and preference between a number of inhaler devices

Trial Identifier: 200301
Sponsor: GlaxoSmithKline
NCTID:: NCT02184624
Start Date: August 2014
Primary Completion Date: July 2015
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Dutch Version

Trial Locations

Country Location
Netherlands ALMERE, Netherlands, 1311 RL
Netherlands BEEK, Netherlands, 6191 JW
Netherlands ENSCHEDE, Netherlands, 7513 ER
Netherlands KLOOSTERHAAR, Netherlands, 7694 AC
Netherlands NIJVERDAL, Netherlands, 7442 LS
Netherlands ZUTPHEN, Netherlands, 7207 AE
United Kingdom Portsmouth, United Kingdom, PO6 3LY
United Kingdom Southampton, United Kingdom, SO16 6YD